tradingkey.logo

Enovis Corp

ENOV
查看详细走势图
22.590USD
+0.800+3.67%
收盘 02/06, 16:00美东报价延迟15分钟
1.29B总市值
亏损市盈率 TTM

Enovis Corp

22.590
+0.800+3.67%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.67%

5天

+2.50%

1月

-21.64%

6月

-20.57%

今年开始到现在

-15.20%

1年

-48.66%

查看详细走势图

TradingKey Enovis Corp股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Enovis Corp当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名41/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价45.45。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Enovis Corp评分

相关信息

行业排名
41 / 205
全市场排名
131 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Enovis Corp亮点

亮点风险
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
业绩高增长
公司营业收入稳步增长,连续3年增长34.84%
利润高增长
公司净利润处于行业前列,最新年度总收入2.11B美元
估值高估
公司最新PE估值-0.93,处于3年历史高位
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值200.74K
活跃度降低
近期活跃度降低,过去20天平均换手率0.36

分析师目标

根据 12 位分析师
买入
评级
45.455
目标均价
+99.27%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Enovis Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Enovis Corp简介

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
公司代码ENOV
公司Enovis Corp
CEOMcdonald (Damien)
网址https://www.enovis.com/
KeyAI